NO20092994L - Anvendelse av et monoklonalt eller polyklonalt antistoff, fremgangsmate og kit for in vitro diagnose samt fremgangsmate for a identifisere og/eller isolere midler - Google Patents

Anvendelse av et monoklonalt eller polyklonalt antistoff, fremgangsmate og kit for in vitro diagnose samt fremgangsmate for a identifisere og/eller isolere midler

Info

Publication number
NO20092994L
NO20092994L NO20092994A NO20092994A NO20092994L NO 20092994 L NO20092994 L NO 20092994L NO 20092994 A NO20092994 A NO 20092994A NO 20092994 A NO20092994 A NO 20092994A NO 20092994 L NO20092994 L NO 20092994L
Authority
NO
Norway
Prior art keywords
monoclonal
kit
identifying
polyclonal antibody
vitro diagnosis
Prior art date
Application number
NO20092994A
Other languages
English (en)
Other versions
NO331148B1 (no
Inventor
Daniel Caput
Pascual Ferrara
Patrick Laurent
Natalio Vita
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092994(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20092994L publication Critical patent/NO20092994L/no
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO331148B1 publication Critical patent/NO331148B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20092994A 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose. NO331148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514424A FR2742156A1 (fr) 1995-12-06 1995-12-06 Polypeptide recepteur de l'il-13
PCT/FR1996/001756 WO1997020926A1 (fr) 1995-12-06 1996-11-07 Polypeptide recepteur de l'il-i3

Publications (2)

Publication Number Publication Date
NO20092994L true NO20092994L (no) 1998-08-05
NO331148B1 NO331148B1 (no) 2011-10-24

Family

ID=9485198

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19982550A NO324775B1 (no) 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse.
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.
NO20092994A NO331148B1 (no) 1995-12-06 2009-09-11 Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO19982550A NO324775B1 (no) 1995-12-06 1998-06-04 Renset peptid, isolert nukleinsyresekvens og deres anvendelse.
NO20074034A NO328197B1 (no) 1995-12-06 2007-08-03 Anvendelse av en probe, anvendelse av en sekvens og fremgangsmate for in vitro diagnose.

Country Status (19)

Country Link
US (4) US7928073B2 (no)
EP (1) EP0876482B1 (no)
JP (3) JP3415162B2 (no)
AR (2) AR004860A1 (no)
AT (1) ATE234922T1 (no)
AU (1) AU7576096A (no)
BR (1) BR9611697B1 (no)
CA (1) CA2238893C (no)
DE (1) DE69626859T2 (no)
DK (1) DK0876482T3 (no)
ES (1) ES2192620T3 (no)
FR (1) FR2742156A1 (no)
MX (1) MX9804419A (no)
MY (1) MY123740A (no)
NO (3) NO324775B1 (no)
PT (1) PT876482E (no)
TW (1) TW565570B (no)
WO (1) WO1997020926A1 (no)
ZA (1) ZA9610238B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911530B1 (en) 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
EP0907730B1 (en) * 1995-10-23 2009-10-07 Zenyth Operations Pty Ltd Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
WO1998010638A1 (en) * 1996-09-10 1998-03-19 Amrad Operations Pty. Ltd. Therapeutic molecules
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
CA2235420A1 (en) 1998-06-17 1999-12-17 Paolo Renzi Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
MXPA01006006A (es) 1998-12-14 2004-08-12 Genetics Inst Cadena receptora de citocina.
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2
EP1268794A2 (en) * 2000-04-07 2003-01-02 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
CA2491320A1 (en) 2002-07-15 2004-01-22 Wyeth Methods and compositions for modulating t helper (th) cell development and function
JP4943161B2 (ja) 2003-12-23 2012-05-30 ジェネンテック， インコーポレイテッド 新規抗ｉｌ１３モノクローナル抗体での癌の処置
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
BRPI0517387A8 (pt) 2004-10-29 2017-07-11 Topigen Pharmaceuticals Inc Oligonucleotídeos anti-senso para o tratamento de alergia e proliferação de células neoplásicas
WO2006055638A2 (en) 2004-11-17 2006-05-26 Abgenix, Inc. Fully human monoclonal antibodies to il-13
GB0615881D0 (en) * 2006-08-10 2006-09-20 Univ Southampton Novel peptide for treatment of asthma
MX2009011366A (es) * 2007-04-23 2009-11-05 Wyeth Corp Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13.
WO2013112871A1 (en) 2012-01-27 2013-08-01 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic il-13 polypeptides
WO2014152361A1 (en) 2013-03-15 2014-09-25 Wake Forest University Health Sciences Antibodies against human and canine il-13ra2
NZ756749A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
WO2015042706A1 (en) 2013-09-24 2015-04-02 Medicenna Therapeutics Pte Ltd Interleukin-4 receptor-binding fusion proteins and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5596072A (en) 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6911530B1 (en) * 1995-10-23 2005-06-28 Amrad Operations, Pty., Ltd. Haemopoietin receptor and genetic sequences encoding same
US5710023A (en) * 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain

Also Published As

Publication number Publication date
ZA9610238B (en) 1998-06-05
DE69626859T2 (de) 2003-12-24
US20050282216A1 (en) 2005-12-22
NO331148B1 (no) 2011-10-24
US20110201029A1 (en) 2011-08-18
MX9804419A (es) 1998-09-30
JP2005323595A (ja) 2005-11-24
ATE234922T1 (de) 2003-04-15
NO324775B1 (no) 2007-12-10
EP0876482B1 (fr) 2003-03-19
NO328197B1 (no) 2010-01-04
WO1997020926A1 (fr) 1997-06-12
MY123740A (en) 2006-06-30
TW565570B (en) 2003-12-11
US20060035856A1 (en) 2006-02-16
AR004860A1 (es) 1999-03-10
JP4185070B2 (ja) 2008-11-19
CA2238893A1 (fr) 1997-06-12
JPH11511028A (ja) 1999-09-28
ES2192620T3 (es) 2003-10-16
PT876482E (pt) 2003-07-31
CA2238893C (fr) 2013-10-08
JP2003180382A (ja) 2003-07-02
DE69626859D1 (de) 2003-04-24
JP3415162B2 (ja) 2003-06-09
AU7576096A (en) 1997-06-27
NO982550D0 (no) 1998-06-04
US7928073B2 (en) 2011-04-19
DK0876482T3 (da) 2003-07-21
US20060035855A1 (en) 2006-02-16
NO20074034L (no) 1998-08-05
FR2742156A1 (fr) 1997-06-13
NO982550L (no) 1998-08-05
AR056723A2 (es) 2007-10-17
JP3737793B2 (ja) 2006-01-25
BR9611697A (pt) 1999-02-17
US8318910B2 (en) 2012-11-27
BR9611697B1 (pt) 2013-09-17
EP0876482A1 (fr) 1998-11-11

Similar Documents

Publication Publication Date Title
NO20092994L (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, fremgangsmate og kit for in vitro diagnose samt fremgangsmate for a identifisere og/eller isolere midler
DE69125992T2 (de) Verfahren und Kit für Immunoassay
NO20065287L (no) Fremgangsmate for maling av tilstedevaerelsen av et OB-polypeptid i en prove
FR2710748B1 (fr) Procédés et dispositif pour tester des moteurs.
DE69635710D1 (de) Eingabegerät für bilderzeugungsverfahren und -gerät
DE69622425T2 (de) Optischer apparat zur durchführung eines immunoassays
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
EP0037110A3 (en) Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
NO976122L (no) AntiFasligandantistoffer og analysefremgangsmåte hvor disse anvendes
DE19681365T1 (de) Ultraschall-Prüfvorrichtung und -verfahren für unterschiedliche Ölfeld-Rohrelemente
IT1219844B (it) Corredo di prova per diagnosi di aids e metodo per effettuare con esso una prognosi per immunopositivi per aids
DK0648335T3 (da) Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
IL123834A0 (en) Diagnostic method and kit for determining rh blood group genotype
EP0827591A4 (en) METHOD FOR DIAGNOSING CHLAMYDIA IN A PATIENT
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
GB9624199D0 (en) Method of evaluating a testing element for antigens or antibodies
AU5186890A (en) Method and diagnostic test kit for detection of autoimmune antibody
FI974424A (fi) Varhainen diagnostinen testi
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
IT1274006B (it) Saggio immunologico per analiti in campioni, che utilizza agenti alchilanti
ITMI930477A0 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
BR8803673A (pt) Hibridoma,mutantes,anticorpo,processos para a preparacao de um hidroma e para a preparacao de um anticorpo,processo para determinacao da existencia de antigeno e kit de teste
ITRM930306A1 (it) Metodo per la evidenziazione di anticorpi anti-achr e corredo diagnostico per la sua realizzazione.
IL113346A (en) Method to identify immunocompromised patients at high risk for cryptococcosis
IT8922805A0 (it) Metodo per la determinazione qualitativa e quantitativa di anticorpi diretti contro antigeni batterici attraverso la misurazione fotometrica dell'agglutinazione

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees